(Q39629785)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3278177%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

review article

1 reference

title

Recent advances in the management of venous thromboembolism (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3278177%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3278177%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

author name string

D N Mohr

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3278177%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

S C Litin

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3278177%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

E C Rosenow

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3278177%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

language of work or name

English

0 references

publication date

1 March 1988

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3278177%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3278177%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

volume

63

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3278177%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3278177%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

page(s)

281-290

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3278177%20AND%20SRC:MED&resulttype=core&format=json

Natural history of pulmonary embolism

22 September 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965102-7

The hypercoagulable states

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965102-7

Molecular Heterogeneity of Inherited Antithrombin III Deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965102-7

Congenital protein C deficiency and venous thromboembolism. A study of three Dutch families

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965102-7

Recurrent venous thromboembolism in patients with a partial deficiency of protein S.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965102-7

Abnormal plasminogen. A hereditary molecular abnormality found in a patient with recurrent thrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965102-7

Venous thrombosis in a family with defective release of vascular plasminogen activator and elevated plasma factor VIII/von Willebrand's factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965102-7

Risk factors for pulmonary embolism. The Framingham Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965102-7

Rates of venous thrombosis after general surgery: combined results of randomised clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965102-7

Intermittent pneumatic calf compression for prevention of deep venous thrombosis in general abdominal surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965102-7

Postoperative venous thrombosis. Evaluation of five methods of treatment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965102-7

Prevention of venous thrombosis by intermittent sequential calf compression in patients with intracranial disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965102-7

External pneumatic calf compression reduces deep venous thrombosis in patients with ruptured intracranial aneurysms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965102-7

Effectiveness of intermittent pulsatile elastic stockings for the prevention of calf and thigh vein thrombosis in patients undergoing elective knee surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965102-7

Prevention of venous thrombosis in patients with intracranial disease by intermittent pneumatic compression of the calf

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965102-7

Effectiveness of leg compression in preventing venous stasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965102-7

Graduated elastic stockings.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965102-7

Prevention of venous thromboembolism after general surgery. Cost-effectiveness analysis of alternative approaches to prophylaxis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965102-7

The Thromboprophylactic Effect of Graded Elastic Compression Stockings in Combination With Dextran 70

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965102-7

A cost-effectiveness analysis of prophylaxis against deep-vein thrombosis in major orthopedic surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965102-7

Prevention of venous thrombosis with small, subcutaneous doses of heparin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965102-7

Low dose heparin: bleeding and wound complications in the surgical patient. A prospective randomized study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965102-7

Low-molecular-weight heparin: is small beautiful?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965102-7

A randomized controlled trial of a low-molecular-weight heparin (enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965102-7

The use of dihydroergotamine and heparin in the prophylaxis of deep venous thrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965102-7

Dihydroergotamine-heparin prophylaxis of postoperative deep vein thrombosis. A multicenter trial. The Multicenter Trial Committee

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965102-7

A meta-analysis of the studies of dihydroergotamine plus heparin in the prophylaxis of deep vein thrombosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965102-7

Adjusted versus fixed-dose subcutaneous heparin in the prevention of deep-vein thrombosis after total hip replacement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965102-7

Replacement of venography in suspected venous thrombosis by impedance plethysmography and 125I-fibrinogen leg scanning: a less invasive approach.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965102-7

Diagnostic efficacy of impedance plethysmography for clinically suspected deep-vein thrombosis. A randomized trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965102-7

Serial impedance plethysmography for suspected deep venous thrombosis in outpatients. The Amsterdam General Practitioner Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965102-7

Radiological (scintigraphic) evaluation of patients with suspected pulmonary thromboembolism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965102-7

Ventilation-perfusion studies in suspected pulmonary embolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965102-7

Pulmonary angiography, ventilation lung scanning, and venography for clinically suspected pulmonary embolism with abnormal perfusion lung scan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965102-7

Diagnostic value of ventilation-perfusion lung scanning in patients with suspected pulmonary embolism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965102-7

Noninvasive venous examinations as a screening test for pulmonary embolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965102-7

The role of noninvasive tests versus pulmonary angiography in the diagnosis of pulmonary embolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965102-7

Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965102-7

A prospective study of the value of monitoring heparin treatment with the activated partial thromboplastin time

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965102-7

In Vivo and Post Mortem Dissolution Rates of Pulmonary Emboli and Venous Thrombi in the Dog

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965102-7

Studies in intravascular coagulation. IV. The effect of heparin and dicumarol on serum-induced venous thrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965102-7

Warfarin. From bedside to bench

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965102-7

Safety and efficacy of warfarin started early after submassive venous thrombosis or pulmonary embolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965102-7

Timing of oral anticoagulation therapy in the treatment of angiographically proven acute pulmonary embolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965102-7

Heparin-associated thrombocytopenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965102-7

Thrombocytopenia occurring during the administration of heparin. A prospective study in 52 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965102-7

Heparin-induced thrombocytopenia. What is its real frequency?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965102-7

Heparin-induced thrombocytopenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965102-7

Heparin-associated thrombocytopenia: a comparison of three heparin preparations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965102-7

Heparin-associated thrombocytopenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965102-7

Immune endothelial-cell injury in heparin-associated thrombocytopenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965102-7

Heparin-induced thrombocytopenia and recurrent thromboembolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965102-7

Heparin-Induced Thrombocytopenia With Thrombosis and Hemorrhage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965102-7

Treatment of heparin-associated thrombocytopenia and thrombosis with low molecular weight heparin (CY 216).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965102-7

Warfarin Sodium versus Low-Dose Heparin in the Long-Term Treatment of Venous Thrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965102-7

Adjusted subcutaneous heparin versus warfarin sodium in the long-term treatment of venous thrombosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965102-7

Need for long-term anticoagulant treatment in symptomatic calf-vein thrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965102-7

One-month versus six-month therapy with oral anticoagulants after symptomatic deep vein thrombosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965102-7

Duration of warfarin anticoagulant therapy and the probabilities of recurrent thromboembolism and hemorrhage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965102-7

Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965102-7

Treatment of venous thromboembolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965102-7

Is the dose of warfarin prescribed by American physicians unnecessarily high?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965102-7

Is embolic risk conditioned by location of deep venous thrombosis?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965102-7

Pulmonary embolism from a venous thrombus located below the knee

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965102-7

Occult pulmonary embolism: a common occurrence in deep venous thrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965102-7

Incidence of pulmonary embolism in the course of thrombophlebitis of the lower extremities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965102-7

Natural history of postoperative deep-vein thrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965102-7

Effect of thrombolytic therapy on pulmonary-capillary blood volume in patients with pulmonary embolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965102-7

Thrombolytic therapy in thrombosis: a National Institutes of Health consensus development conference

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965102-7

Acute pulmonary embolism treated with tissue plasminogen activator

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965102-7

10.1016/S0025-6196(12)65102-7

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3278177%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

1 reference